7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Revolution Medicines, Inc
(NASDAQ:RVMD) 

RVMD stock logo

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gyne...

Founded: 2014
Full Time Employees: 117
CEO: Mark A. Goldsmith  
Sector: Healthcare
Industry: Biotechnology
Pharmaceuticals
Share this website to your friends
Revolution Medicines Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0346.1692.191,038.291,384.381,730.482,076.572,422.67
Revolution Medicines Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 010.7621.5232.2843.0453.864.5675.32
Revolution Medicines Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.26-2.79-2.33-1.86-1.4-0.93-0.470
Revolution Medicines Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.36-2.88-2.4-1.92-1.44-0.96-0.480
Revolution Medicines Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.873.755.627.59.3711.2513.12
Revolution Medicines P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 063.53127.06190.59254.13317.66381.19444.72
Revolution Medicines (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -7,727.13-6,623.26-5,519.38-4,415.5-3,311.63-2,207.75-1,103.88-0
Revolution Medicines P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0263.77527.54791.311,055.081,318.851,582.621,846.39
No extra charts and metrics for this ticker.